MercoPress, en Español
Montevideo, March 28th 2024 - 21:10 UTC
The United States Supreme Court ruled on Thursday that companies cannot patent parts of naturally-occurring human genes, a decision with the potential to profoundly affect the emerging and lucrative medical and biotechnology industries.
Get our news on your inbox! Suscribe